CSBR:NASDAQ
Champions Oncology Inc
$4.79
arrow_upward
+0.63%(+0.030) 1D
Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.78
High
$4.87
Low
$4.75
Mkt. cap
66.67M
Avg. vol.
9.42K
Volume
4.25K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.78
High
$4.87
Low
$4.75
Mkt. cap
66.67M
Avg. vol.
9.42K
Volume
4.25K
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
TradingView
·
8 hours ago
Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com